Effect of Thalidomide on Clinical Remission in Children and Adolescents With Refractory Crohn Disease-Reference-Cited by-同舟云学术

Effect of Thalidomide on Clinical Remission in Children and Adolescents With Refractory Crohn Disease

Published:2013-11-27 Issue:20 Volume:310 Page:2164
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Lazzerini Marzia,Martelossi Stefano,Magazzù Giuseppe,Pellegrino Salvatore,Lucanto Maria Cristina,Barabino Arrigo,Calvi Angela,Arrigo Serena,Lionetti Paolo,Lorusso Monica,Mangiantini Francesca,Fontana Massimo,Zuin Giovanna,Palla Gabriella,Maggiore Giuseppe,Bramuzzo Matteo,Pellegrin Maria Chiara,Maschio Massimo,Villanacci Vincenzo,Manenti Stefania,Decorti Giuliana,De Iudicibus Sara,Paparazzo Rossella,Montico Marcella,Ventura Alessandro

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and management of inflammatory bowel disease;Journal of Evidence-Based Medicine;2024-06

2. Signaling pathways in macrophages: molecular mechanisms and therapeutic targets;MedComm;2023-09-11

3. Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel disease;Biomedicine & Pharmacotherapy;2023-08

4. Comparison and development of machine learning for thalidomide-induced peripheral neuropathy prediction of refractory Crohn’s disease in Chinese population;World Journal of Gastroenterology;2023-06-28

5. A phase 2 study of thalidomide for the treatment of radiation-induced blood-brain barrier injury;Science Translational Medicine;2023-02-22